Precision Oncology Global Market Report 2025

Description

Precision oncology is a medical strategy that customizes cancer treatment based on the unique characteristics of each patient. This approach leverages molecular and genetic profiling of tumors to identify specific mutations, biomarkers, or pathways that drive cancer progression, enabling clinicians to choose targeted therapies that are more likely to be effective and cause fewer side effects compared to conventional treatments.

The primary categories of precision oncology include genomic sequencing and immunotherapy. Genomic sequencing involves determining the complete DNA sequence of an organism's genome at a given time. Key product offerings in this domain include genetic tests, biomarker-based assays, and targeted therapeutics, which are applied in treating various cancers such as breast, lung, colorectal, prostate, skin, stomach, and others. Supporting technologies encompass next-generation sequencing, bioinformatics, molecular imaging, and liquid biopsy. The primary end users include hospitals, research laboratories, pharmaceutical companies, and diagnostic centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The precision oncology market research report is one of a series of new reports from The Business Research Company that provides precision oncology market statistics, including the precision oncology industry's global market size, regional shares, competitors with the precision oncology market share, detailed precision oncology market segments, market trends and opportunities, and any further data you may need to thrive in the precision oncology market. This precision oncology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The precision oncology market size has grown rapidly in recent years. It will grow from $95.73 billion in 2024 to $106.21 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth during the historic period can be credited to the increasing number of companion diagnostics approvals, heightened focus on biomarker discovery and validation, growing investments in oncology research and innovation, a rising number of precision oncology clinical trials, and the increasing preference for minimally invasive diagnostic methods.

The precision oncology market size is expected to see rapid growth in the next few years. It will grow to $158.90 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to the rising prevalence of cancer cases, increasing adoption of genomics-based diagnostics, growing awareness among patients and healthcare providers, expanding utilization of next-generation sequencing, and the rising demand for targeted cancer therapies. Key trends during this period include advancements in liquid biopsy technologies, increased application of single-cell sequencing for tumor analysis, development of decentralized testing platforms, innovations in radiogenomics for treatment planning, and progress in patient-specific cancer vaccines.

The rising adoption of personalized therapies is expected to drive growth in the precision oncology market. Personalized therapies are treatments tailored to an individual's genetic makeup, biomarkers, and specific disease characteristics to enhance effectiveness and minimize side effects. The increasing adoption of these therapies is fueled by advances in genomic technologies that allow precise identification of disease-driving mutations, enabling more targeted and effective cancer treatments. Precision oncology supports personalized therapies by using genomic and molecular profiling to design cancer treatments specific to a patient's tumor genetics. For example, in February 2023, according to GOV.UK, the Health and Social Care Secretary in the UK signed a memorandum of understanding (MoU) with BioNTech SE to advance cancer vaccine research, with the goal of delivering 10,000 personalized therapy doses to UK patients by 2030. This demonstrates how growing awareness and adoption of personalized therapies are driving precision oncology market growth.

Companies in the precision oncology market are developing genomic-driven innovations to enhance personalized cancer care. One such innovation is the molecular tumor board, a panel of specialists that interprets complex genomic and molecular test data to guide precision-driven cancer therapies tailored to each patient's tumor characteristics. For instance, in December 2024, Aster DM Healthcare Ltd., a UAE-based healthcare provider, launched a precision oncology clinic as part of three initiatives aimed at transforming cancer treatment through data-driven, genomic-focused strategies. This clinic provides customized therapy based on a patient's tumor genetic profile, improving treatment outcomes, reducing toxicity, and enhancing quality of life.

In March 2024, Bayer AG, a Germany-based pharmaceutical company, partnered with Aignostics GmbH to advance AI-driven precision oncology. This collaboration leverages Aignostics' computational pathology and AI technologies to analyze patient data, supporting the discovery and development of more effective, personalized cancer treatments. Aignostics GmbH specializes in AI solutions designed to enhance precision oncology research and patient care.

Major players in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Eli Lilly and Company, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.

North America was the largest region in the precision oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in precision oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the precision oncology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The precision oncology market consists of revenues earned by entities by providing services such as genomic and molecular profiling services, companion diagnostics services, and personalized treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The precision oncology market also includes sales of genomic and molecular diagnostic equipment, immune checkpoint inhibitors, and bioinformatics and decision support tools. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Precision Oncology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on precision oncology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for precision oncology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The precision oncology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Genomic Sequencing; Immunotherapy
2) By Product Type: Genetic Tests; Biomarker-Based Tests; Therapeutics
3) By Cancer Type: Breast Cancer; Lung Cancer; Colorectal Cancer; Prostate Cancer; Skin Cancer; Stomach Cancer; Other Cancers
4) By Technology: Next-Generation Sequencing; Bioinformatics; Molecular Imaging; Liquid Biopsy
5) By End-users: Hospitals; Research Laboratories; Pharmaceutical Companies; Diagnostic Centers
Subsegments:
1) By Genomic Sequencing: Whole Genome Sequencing; Whole Exome Sequencing; Targeted Gene Sequencing
2) By Immunotherapy: Immune Checkpoint Inhibitors; Cancer Vaccines; Adoptive Cell Therapy
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Bayer AG; Bristol Myers Squibb Company; Thermo Fisher Scientific Inc.; AstraZeneca plc.; Novartis AG; Eli Lilly and Company; Amgen Inc.; Agilent Technologies Inc.; Illumina Inc.; Sysmex Corporation; Qiagen N.V.; Exact Sciences Corporation; NeoGenomics Laboratories Inc.; Myriad Genetics Inc.; Invitae Corporation; Caris Life Sciences; Foundation Medicine Inc.; NanoString Technologies Inc.; Personalis Inc.; Strata Oncology Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37866

1. Executive Summary

2. Precision Oncology Market Characteristics

3. Precision Oncology Market Trends And Strategies

4. Precision Oncology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Precision Oncology Growth Analysis And Strategic Analysis Framework

5.1. Global Precision Oncology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Precision Oncology Market Growth Rate Analysis
5.4. Global Precision Oncology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Precision Oncology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Precision Oncology Total Addressable Market (TAM)

6. Precision Oncology Market Segmentation

6.1. Global Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genomic Sequencing
Immunotherapy
6.2. Global Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genetic Tests
Biomarker-Based Tests
Therapeutics
6.3. Global Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Skin Cancer
Stomach Cancer
Other Cancers
6.4. Global Precision Oncology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Next-Generation Sequencing
Bioinformatics
Molecular Imaging
Liquid Biopsy
6.5. Global Precision Oncology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Research Laboratories
Pharmaceutical Companies
Diagnostic Centers
6.6. Global Precision Oncology Market, Sub-Segmentation Of Genomic Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Gene Sequencing
6.7. Global Precision Oncology Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immune Checkpoint Inhibitors
Cancer Vaccines
Adoptive Cell Therapy

7. Precision Oncology Market Regional And Country Analysis

7.1. Global Precision Oncology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Precision Oncology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Precision Oncology Market

8.1. Asia-Pacific Precision Oncology Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Precision Oncology Market

9.1. China Precision Oncology Market Overview
9.2. China Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Precision Oncology Market

10.1. India Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Precision Oncology Market

11.1. Japan Precision Oncology Market Overview
11.2. Japan Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Precision Oncology Market

12.1. Australia Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Precision Oncology Market

13.1. Indonesia Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Precision Oncology Market

14.1. South Korea Precision Oncology Market Overview
14.2. South Korea Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Precision Oncology Market

15.1. Western Europe Precision Oncology Market Overview
15.2. Western Europe Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Precision Oncology Market

16.1. UK Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Precision Oncology Market

17.1. Germany Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Precision Oncology Market

18.1. France Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Precision Oncology Market

19.1. Italy Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Precision Oncology Market

20.1. Spain Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Precision Oncology Market

21.1. Eastern Europe Precision Oncology Market Overview
21.2. Eastern Europe Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Precision Oncology Market

22.1. Russia Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Precision Oncology Market

23.1. North America Precision Oncology Market Overview
23.2. North America Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Precision Oncology Market

24.1. USA Precision Oncology Market Overview
24.2. USA Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Precision Oncology Market

25.1. Canada Precision Oncology Market Overview
25.2. Canada Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Precision Oncology Market

26.1. South America Precision Oncology Market Overview
26.2. South America Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Precision Oncology Market

27.1. Brazil Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Precision Oncology Market

28.1. Middle East Precision Oncology Market Overview
28.2. Middle East Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Precision Oncology Market

29.1. Africa Precision Oncology Market Overview
29.2. Africa Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Precision Oncology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Precision Oncology Market Competitive Landscape And Company Profiles

30.1. Precision Oncology Market Competitive Landscape
30.2. Precision Oncology Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Precision Oncology Market Other Major And Innovative Companies

31.1. AstraZeneca plc.
31.2. Novartis AG
31.3. Eli Lilly and Company
31.4. Amgen Inc.
31.5. Agilent Technologies Inc.
31.6. Illumina Inc.
31.7. Sysmex Corporation
31.8. Qiagen N.V.
31.9. Exact Sciences Corporation
31.10. NeoGenomics Laboratories Inc.
31.11. Myriad Genetics Inc.
31.12. Invitae Corporation
31.13. Caris Life Sciences
31.14. Foundation Medicine Inc.
31.15. NanoString Technologies Inc.

32. Global Precision Oncology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Precision Oncology Market

34. Recent Developments In The Precision Oncology Market

35. Precision Oncology Market High Potential Countries, Segments and Strategies

35.1 Precision Oncology Market In 2029 - Countries Offering Most New Opportunities
35.2 Precision Oncology Market In 2029 - Segments Offering Most New Opportunities
35.3 Precision Oncology Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer